510(k) Report

FDA product code · Ophthalmic

Artificial Iris

QBTClass IIIPMA required1 decision since 20180 recalls

1 FDA decision since 2018. No recall names this code.

Artificial iris is intended to be implanted to replace the natural iris of the eye.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, ophthalmic panel

Twenty years of QBT at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QBT

1in 2020

2018: 12019: 22020: 1
2007high 2 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QBT

Too few QBT 510(k)s in any year since 2007 to give a median.

Recalls per year · QBT

No recall names QBT since 2007.

Adverse event reports per year · QBT

No MAUDE report names QBT since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20192—00
20201—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — QBT by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QBT? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report